p21 CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
p21 CIP1/WAF1 is a downstream effector of tumor suppressors and functions as a cyclin-dependent kinase inhibitor to block cellular proliferation. Breast tumors may derive from self-renewing tumor-initiating cells (BT-ICs), which contribute to tumor progression, recurrence, and therapy resistance. The role of p21 CIP1 in regulating features of tumor stem cells in vivo is unknown. Herein, deletion of p21 CIP1 , which enhanced the rate of tumorigenesis induced by mammary-targeted Ha-Ras or c-Myc, enhanced gene expression profiles and immunohistochemical features of epithelial mesenchymal transition (EMT) and putative cancer stem cells in vivo. Silencing of p21 CIP1 enhanced, and expression of p21 CIP1 repressed, features of EMT in transformed immortal human MEC lines. p21 CIP1 attenuated oncogene-induced BT-IC and mammosphere formation. Thus, the in vitro cell culture assays reflect the changes observed in vivo in transgenic mice. These findings establish a link between the loss of p21 CIP1 and the acquisition of breast cancer EMT and stem cell properties in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“Cancer stem cells can be enriched by sorting for CD44 /CD24 /low cells (11).”
BackgroundThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“Epithelial cells from murine or human mammary glands or tumors contain stem-like cells that express EMT markers, suggesting a link between EMT and the gain of epithelial stem-like properties (12).”
BackgroundWAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 4×
“p21CIP1 inhibits cellular growth in tissue culture and tumor xenograft formation (3, 5).”
BackgroundInfluentialIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505 · cited 5×
“Gene targets of Sox2, Oct4, and Nanog were enriched among p21CIP1 target genes.”
BackgroundMethodInfluentialA human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“The epithelial marker ZO-1 (17) was reduced and the mesenchymal marker N-cadherin was increased by Ha-Ras expression or c-Myc transduction (Fig.”
BackgroundBen-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523 · cited 2×
“Our hierarchical clustering, comparing p21CIP1-regulated genes in the mammary tumor with gene sets associated with ES cell identity (19), demonstrated p21CIP1-repressed genes were enriched in ES cells.”
BackgroundMethodIn vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 1×
“TICs form non-adherent mammospheres, similar to normal mammary gland stem cells when cultured under specific conditions in the absence of serum (22, 23).”
BackgroundGeneration of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005
Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,723 · cited 1×
“TICs form non-adherent mammospheres, similar to normal mammary gland stem cells when cultured under specific conditions in the absence of serum (22, 23).”
BackgroundHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339 · cited 9×
“Self-renewal of primitive HSCs requires p21CIP1 and was defective in p21CIP1 / mice, suggesting p21CIP1 functions as a molecular switch governing HSC cycle entry.”
BackgroundInfluentialCDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152 · cited 1×
“In contrast, APC mutation and p18INKC-deficiencydependent tumorigenesis (7), and mammary gland targeted Ha-Ras or c-Myc-induced tumorigenesis, were each enhanced by p21CIP1 deficiency (8).”
BackgroundRodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061 · cited 1×
“Point mutation of S35 in Ras (V12/35S) abrogates JNK without affecting ERK signaling (18) and remained capable of inducing the Twist promoter, whereas the 37G and 40C mutations, which abolish MAPK and PI3K signaling (18) respectively, were incapable of activating Twist (Fig.”
BackgroundThe Biology of Cancer Stem Cells
Lobo, N. A., Shimono, Y., Qian, D., & Clarke, M. F. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104154 · Cited by 1,043 · cited 1×
“Cancer stem cells possess SC-like traits (26).”
Self-renewal and solid tumor stem cells
Al-Hajj, M., & Clarke, M. F. (2004) · Oncogene · doi:10.1038/sj.onc.1207947 · Cited by 914 · cited 1×
“Only a small number of primary breast cancer cells, known as cancer stem cells or TICs, form secondary tumors (21).”
BackgroundVerrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664 · cited 1×
“In the context of c-Myc, p21CIP1 inhibited features of the known EMT-inducing pathways TGF and NF- B (15, 16) (Fig.”
BackgroundOct-3/4 is a dose-dependent oncogenic fate determinant
Gidekel, S., Pizov, G., Bergman, Y., & Pikarsky, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00270-8 · Cited by 441 · cited 1×
“Some of the key regulators of ES cell identity, Oct4, Sox2, KLF4, and Nanog (27), are expressed in specific tumors (28, 29).”
BackgroundDirect Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., Creasap, N., Rosol, T. J., Robinson, M. L., Eng, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2148 · Cited by 368 · cited 1×
“These findings are consistent with findings that markers of EMT are induced in human and murine mammary tumors associated with c-Myc amplification (24).”
ResultLi, Q.-Q., Xu, J.-D., Wang, W.-J., Cao, X.-X., Chen, Q., Tang, F., Chen, Z.-Q., Liu, X.-P., & Xu, Z.-D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2372 · Cited by 338 · cited 1×
“These findings are consistent with recent findings that endogenous Twist maintains p21CIP1 gene expression and the EMT phenotype at MCF7 cells (25).”
ResultMissero, C., Di Cunto, F., Kiyokawa, H., Koff, A., & Dotto, G. P. (1996) · Genes & Development · doi:10.1101/gad.10.23.3065 · Cited by 312 · cited 1×
“p21CIP1 inhibits cellular growth in tissue culture and tumor xenograft formation (3, 5).”
BackgroundExpression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294 · cited 1×
“Comparison between the MMTV-c-Myc and MMTV-Ras tumors and normal mammary epithelial glands demonstrated altered gene expression profiles reflecting the induction of features of EMT (13) (Fig.”
BackgroundSox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Rodriguez-Pinilla, S. M., Sarrio, D., Moreno-Bueno, G., Rodriguez-Gil, Y., Martinez, M. A., Hernandez, L., Hardisson, D., Reis-Filho, J. S., & Palacios, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800760 · Cited by 242 · cited 1×
“Some of the key regulators of ES cell identity, Oct4, Sox2, KLF4, and Nanog (27), are expressed in specific tumors (28, 29).”
BackgroundRatio statistics of gene expression levels and applications to microarray data analysis
Chen, Y., Kamat, V., Dougherty, E. R., Bittner, M. L., Meltzer, P. S., & Trent, J. M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.9.1207 · Cited by 177 · cited 1×
“Analysisof thearrayswasperformedusingtheRstatisticspackage(31)”
Hinata, K., Gervin, A. M., Zhang, J. Y., & Khavari, P. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206198 · Cited by 130 · cited 1×
“In the context of c-Myc, p21CIP1 inhibited features of the known EMT-inducing pathways TGF and NF- B (15, 16) (Fig.”
BackgroundThe properties of a mammary gland cancer stem cell
Zucchi, I., Sanzone, S., Astigiano, S., Pelucchi, P., Scotti, M. A., Valsecchi, V., Barbieri, O., Bertoli, G. R., Albertini, A., Reinbold, R. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703071104 · Cited by 108 · cited 2×
“In addition to these previously described hallmarks, recent studies implicate epithelial mesenchymal transition (EMT) and tumor cancer stem cells (or tumor-initiating cells) in tumor progression (2).”
BackgroundDifferential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., & Windle, J. J. (2002) · PubMed · Cited by 77
Self-citationEdelman, E., Porrello, A., Guinney, J., Balakumaran, B., Bild, A., Febbo, P. G., & Mukherjee, S. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl231 · Cited by 75
Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration
Li, Z., Wang, C., Jiao, X., Katiyar, S., Casimiro, M. C., Prendergast, G. C., Powell, M. J., & Pestell, R. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706992200 · Cited by 57
Self-citationSomatic cell type specific gene transfer reveals a tumor-promoting function for p21Waf1/Cip1
Liu, Y., Yeh, N., Zhu, X.-H., Leversha, M., Cordon-Cardo, C., Ghossein, R., Singh, B., Holland, E., & Koff, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601886 · Cited by 52 · cited 1×
“PDGF-induced gliomagenesis, and ATM / and p53 / mediated tumorigenesis was reduced in the p21CIP1-deficient background, suggesting a tumor promoting function of p21CIP1 (6).”
BackgroundErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells
Lindsay, J., Jiao, X., Sakamaki, T., Casimiro, M. C., Shirley, L. A., Tran, T. H., Ju, X., Liu, M., Li, Z., Wang, C., et al. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00041.x · Cited by 46
Self-citation
Cited by
Chen, T., You, Y., Jiang, H., & Wang, Z. Z. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25797 · Cited by 560
Balko, J. M., Giltnane, J. M., Wang, K., Schwarz, L. J., Young, C. D., Cook, R. S., Owens, P., Sanders, M. E., Kuba, M. G., Sánchez, V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0286 · Cited by 482
The epithelial–mesenchymal transition (EMT) phenomenon
Savagner, P. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq292 · Cited by 413
Xu, J., Chen, Y., & Olopade, O. I. (2010) · Genes & Cancer · doi:10.1177/1947601910378691 · Cited by 382
Wen, S., Hou, Y., Fu, L., Xi, L., Yang, D., Zhao, M., Qin, Y., Sun, K., Teng, Y., & Liu, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.10.015 · Cited by 344
Self-citation
Metadata
- Authors
- Liu, M., Casimiro, M. C., Wang, C., Shirley, L. A., Jiao, X., Katiyar, S., Ju, X., Li, Z., Yu, Z., Zhou, J., Johnson, M., Fortina, P., Hyslop, T., Windle, J. J., & Pestell, R. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-11-10
- Volume
- 106
- Issue
- 45
- Pages
- 19035-19039
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1990373054
- Cited by
- 171
- References
- 34
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.